Ilmarinen Mutual Pension Insurance Co Grows Stock Holdings in Humana Inc. $HUM

Ilmarinen Mutual Pension Insurance Co boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 47.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,000 shares of the insurance provider’s stock after purchasing an additional 4,500 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Humana were worth $3,586,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after purchasing an additional 106,030 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in Humana by 28.9% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after acquiring an additional 1,008,514 shares during the last quarter. Pzena Investment Management LLC increased its stake in Humana by 1.0% during the fourth quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock worth $1,043,015,000 after acquiring an additional 41,125 shares during the last quarter. Geode Capital Management LLC increased its stake in Humana by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider’s stock worth $812,540,000 after acquiring an additional 23,732 shares during the last quarter. Finally, Capital International Investors bought a new stake in Humana during the third quarter worth approximately $707,670,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Down 0.9%

HUM opened at $305.97 on Friday. The stock has a market cap of $36.74 billion, a price-to-earnings ratio of 32.72, a P/E/G ratio of 2.24 and a beta of 0.68. The stock’s 50 day moving average price is $231.96 and its 200-day moving average price is $229.04. Humana Inc. has a one year low of $163.11 and a one year high of $315.66. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts forecast that Humana Inc. will post 9.01 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana’s dividend payout ratio is presently 37.86%.

Analysts Set New Price Targets

HUM has been the topic of several analyst reports. UBS Group boosted their price objective on Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. JPMorgan Chase & Co. boosted their price objective on Humana from $180.00 to $214.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Evercore boosted their price objective on shares of Humana from $195.00 to $250.00 in a research report on Thursday, April 30th. Raymond James Financial reiterated an “outperform” rating and set a $260.00 price objective on shares of Humana in a research report on Friday, May 1st. Finally, Seaport Research Partners cut shares of Humana to a “neutral” rating in a research report on Wednesday, May 20th. Nine analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, Humana presently has an average rating of “Hold” and an average target price of $270.48.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.